GENE ONLINE|News &
Vivoryon Therapeutics Announces April 2026 Participation in Upcoming Investor Conference
Vivoryon Therapeutics N.V., a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative diseases, has announced its participation in an upcoming investor conference. The event is scheduled to take place in the near future, providing the company with an opportunity to engage with investors and discuss its ongoing projects and developments.
The announcement was made on April 9, 2026, through official channels. Vivoryon Therapeutics specializes in advancing therapeutic solutions aimed at addressing conditions such as Alzheimer’s disease. The company’s attendance at the conference aligns with its efforts to maintain transparency with stakeholders and share updates on its progress within the pharmaceutical sector. Further details regarding the specific date, location, or agenda of the conference have not been disclosed at this time.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 9, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Study Identifies Unique Risk Factors and Injury Patterns in Preterm Infants with PAIS and CSVT
2026-04-17
Study Finds Gaps in Measles Vaccination Coverage and Awareness Among U.S. Emergency Room Patients
2026-04-17
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
